Status:

COMPLETED

Relative Oral Bioavailability of GABA From Tomatoes

Lead Sponsor:

Wageningen University

Collaborating Sponsors:

Nunhems

Agrico Research

Conditions:

GABA Plasmakinetics

Eligibility:

MALE

18-28 years

Phase:

NA

Brief Summary

In this four-way crossover study, a plasmakinetic profile of GABA from tomatoes as compared to a gamma-aminobutyric acid (GABA) supplement in healthy young men will be established. In addition, a plas...

Eligibility Criteria

Inclusion

  • BMI between 18.5 and 25 kg/m2
  • Age is between 18 and 28 years
  • Good general health
  • Male
  • Veins suitable for blood sampling
  • Able to speak Dutch

Exclusion

  • Is currently suffering from a disease including mental disorders
  • Has had any gastrointestinal condition/disease within the 3 months prior to the intervention
  • Haemoglobin (Hb) level \< 8.5 mmol/L
  • Has used medication in the two months before and/or during the intervention. Occasional use of NSAIDs or paracetamol (\<once a week on average) are is allowed.
  • Reported weight loss or weight gain of \> 2 kg in the month prior to the intervention
  • Use of dietary supplements, 3 weeks before-, or during the intervention.
  • Allergic to products that are provided as part of the standardised diet
  • Unwilling to consume the products that are part of the standardised diet
  • Allergic to tomatoes
  • (History of) drug abuse, in this case meaning \>1 x per month use of recreational drugs
  • Smoking
  • Alcohol consumption of \>10 standardised glasses per week.
  • Not able to refrain from alcohol consumption 2 days before each test day
  • Recent or planned blood donation (\<3 month prior to first study day or during intervention)
  • Personnel of Wageningen University, department of Human Nutrition and Health,
  • Currently participating in other research or was participating in another study within 1 month of the intervention or within 3 months if invasive procedures were used.

Key Trial Info

Start Date :

November 4 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 5 2019

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT04086108

Start Date

November 4 2019

End Date

December 5 2019

Last Update

January 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wageningen University, Division of Human Nutrition

Wageningen, Netherlands